How do corticosteroid medications help control autoimmune connective tissue diseases?

Corticosteroid medications, which include synthetic glucocorticoids such as prednisone, methylprednisolone, and dexamethasone, are essential in managing autoimmune connective tissue diseases by modulating the body's overactive immune response.123

These medications function through several key mechanisms:

• Anti-inflammatory Action: At a cellular level, glucocorticoids inhibit the production and action of inflammatory cytokines. They also reduce the synthesis of proteins that mediate the inflammatory response and inhibit enzymes like phospholipase A2, which are involved in producing inflammatory mediators such as prostaglandins and leukotrienes.13
• Immunosuppression: In higher doses, these drugs impair the function of the immune system. This reduces cell-mediated immune reactions and decreases the production and activity of antibodies, which is critical for conditions like systemic lupus erythematosus where the body produces damaging autoantibodies.14

While these treatments are highly effective at controlling inflammation and limiting organ damage, they carry risks of serious side effects with long-term use, such as osteoporosis, weight gain, and increased susceptibility to infections. Therefore, they are typically prescribed with careful clinical oversight.145